RICHLAND, Wash.--(BUSINESS WIRE)-- IsoRay Inc. (AMEX: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications, today announced it will host a booth ...
Lung Cancer Originating in Uterus Treated With Cs-131 Internal Radiation Therapy Lung cancer is the leading cause of cancer deaths worldwide. Each year, over 222,500 Americans develop primary lung ...
RICHLAND, Wash., Sept. 25, 2017 /PRNewswire/ -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company and innovator in seed brachytherapy and medical radioisotope applications for the treatment ...
RICHLAND, Wash., March 31, 2021 (GLOBE NEWSWIRE) -- A recently published small prospective series of patients with recurrent head and neck (H&N) cancers treated with surgical resection and Isoray’s ...
RICHLAND, Wash., June 02, 2020 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR) today announced that the results of a new ten year study show positive outcomes for low-risk and intermediate-risk ...
RICHLAND, Wash & CORALVILLE, IOWA, June 16, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and ...
Looking to treat early stage lung cancer patients well, an increasing number of hospitals and medical treatment centers are using IsoRay’s proprietary mesh Cesium-131 (Cs-131) brachytherapy seeds ...
High grade gliomas (a type of brain cancer that includes glioblastoma multiforme) are among the most difficult-to-treat cancers, with the majority of these cancers recurring despite aggressive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results